“Coronary Artery Disease. We see you.” Quite literally, healthcare company Artrya (ASX: AYA) sees your heart disease through its artificial intelligence solution Salix, which uses AI imaging to detect the intensity of your heart disease and aims to leverage its tech to access a global market alongside another jab at its FDA approval. In June
Read More
With increasing health awareness across China, medtech company Optiscan (ASX: OIL) is set to increase the exposure of their in vivo microscopic imaging camera which can be thread through the human body for use in cancer detection and surgery. The increased exposure will come through a freshly inked distribution partnership with biotech company Sinsi Technology
Read More
Phenylketonuria. Most people won’t know what it is, let alone how to say it, let alone spell it. But for the few who do, they know it’s a serious birth defect that can have devastating effects. Also known as PKU, phenylketonuria is a very rare, congenital disorder that causes a build up of amino acid
Read More
Despite their claims of being able to improve millions of lives by providing better sleep at night using their bite fork mouthguards to treat sleep apnea, medtech company Oventus Medical (ASX: OVN) will never have the opportunity to prove that statement correct having entered Voluntary Administration amid mounting debt and their sales hitting the snooze
Read More
If you’ve ever wanted to determine the cause of that ache, pain, cough or sniffle sans doctor, you’ve likely found yourself at Healthdirect’s symptom checker. Aside from hosting a hypochondriac’s best friend, Healthdirect is a valuable resource, providing free Australian health advice. The government-funded service comprises a website, a National Health Services Directory and a
Read More
Coronary heart disease is the most prevalent type of heart disease and the leading single cause of death in Australia, representing 11% of all deaths in 2018. 42% of coronary heart disease related deaths resulted from a heart attack. Medtech company Artrya (ASX: AYA) is working to improve diagnosis of this often silent disease. Their
Read More